share_log

Benchmark Maintains Buy on Nutex Health, Lowers Price Target to $2.5

Benzinga ·  May 17, 2023 08:18

Benchmark analyst Bill Sutherland maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $3 to $2.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment